Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Kinetics of COVID-19-neutralising Antibodies in Patients Residing in EHPAD / USLD: Influence of Immunosenescence

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04563650
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:50.785518+00:00
Published At
2024-04-10T00:00:00+00:00
Record Updated At
2024-04-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Covid19", "Geriatric Medicine", "Seroconversion", "Immunosenescence"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-04-10"
protocolSection.identificationModule.nctId
"NCT04563650"
protocolSection.identificationModule.officialTitle
"Kinetics of COVID-19-neutralising Antibodies in Patients Residing in EHPAD / USLD: Influence of Immunosenescence"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Covid19 (protocolSection.conditionsModule.conditions)
  • Geriatric Medicine (protocolSection.conditionsModule.conditions)
  • Seroconversion (protocolSection.conditionsModule.conditions)
  • Immunosenescence (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.